Pluristem's Phase I/II Muscle Injury Trial Results to be Announced on January 21, 2014

Pluristem Therapeutics

today announced that the results of the company's Phase I/II clinical trial testing the safety and efficacy of PLacental Expanded (PLX-PAD) cells for the treatment of muscle injury will be presented on January 21, 2014.